San Román J A, Vilacosta I, Castillo J A, Rollán M J, Sánchez-Harguindey L
Departamento de Ecocardiografía, Hospital Universitario de San Carlos, Madrid.
Rev Esp Cardiol. 1994 Apr;47(4):221-6.
Echocardiography with dobutamine has been proposed as a useful tool in the diagnosis and assessment of coronary artery disease.
To determine the usefulness of echocardiography combined with dobutamine infusion (10 micrograms/kg/min, with increments of 10 micrograms/kg/min every 3 min up to 40 micrograms/kg/min) and atropine if submaximal heart rate is not achieved in detecting coronary artery disease, 45 patients with chest pain underwent this test, exercise stress test and coronary angiography.
No significant differences were found between double product (peak heart rate x systolic pressure) after dobutamine infusion (18,774) and after exercise (16,950; p = NS). Significant coronary artery disease, defined as having 70% stenosis in, at least, one major vessel, was present in 30 patients. Although overall sensitivity of dobutamine echocardiography test (70%) was similar than that obtained by exercise stress test (66%), sensitivity of the subgroup of patients with single-vessel disease was significantly higher (66 vs 42%, respectively; p < 0.05). Specificity was slightly higher with dobutamine echocardiography test (94%) than with exercise stress test (66%; p = 0.07). Side effects and major complications (hypotension, ventricular tachycardia, heart failure) were present in 8 (18%) and 3 (6%) patients, respectively. ECG during dobutamine administration become positive for ischemia in 17 patients with and 1 without coronary artery disease.
Dobutamine echocardiography test is highly sensitive and specific for the detection of coronary artery disease. Its sensitivity in patients with single-vessel disease is better than that obtained by exercise stress test. Complications after dobutamine infusion must be kept in mind.
多巴酚丁胺超声心动图已被认为是诊断和评估冠状动脉疾病的一种有用工具。
为了确定超声心动图联合多巴酚丁胺输注(10微克/千克/分钟,每3分钟增加10微克/千克/分钟,直至40微克/千克/分钟)以及在未达到次极量心率时联合阿托品用于检测冠状动脉疾病的有效性,45例胸痛患者接受了此项检查、运动负荷试验和冠状动脉造影。
多巴酚丁胺输注后(18,774)与运动后(16,950;p =无显著差异)的双乘积(峰值心率×收缩压)无显著差异。30例患者存在严重冠状动脉疾病,定义为至少一支主要血管狭窄达70%。尽管多巴酚丁胺超声心动图试验的总体敏感性(70%)与运动负荷试验(66%)相似,但单支血管疾病患者亚组的敏感性显著更高(分别为66%和42%;p < 0.05)。多巴酚丁胺超声心动图试验的特异性(94%)略高于运动负荷试验(66%;p = 0.07)。分别有8例(18%)和3例(6%)患者出现副作用和主要并发症(低血压、室性心动过速、心力衰竭)。多巴酚丁胺给药期间,17例有冠状动脉疾病和1例无冠状动脉疾病的患者心电图出现缺血阳性。
多巴酚丁胺超声心动图试验对冠状动脉疾病的检测具有高度敏感性和特异性。其对单支血管疾病患者的敏感性优于运动负荷试验。必须牢记多巴酚丁胺输注后的并发症。